Type 1 Diabetes
Explore facts and recommendations for pharmacological treatments for type 1 diabetes.
We didn't find any resources that match your selection.
Please adjust your filter(s) and try again.
GLP-1 RA Mechanism of Action (IME Content)
Visual review of GLP-1 RA's mechanism of action.
Get Smart: Leveraging New Technologies to Optimize Diabetes Management (IME Content)
Review of continuous glucose monitoring, various insulin delivery methods and associated ADA, EASD and AACE guidance. Also highlights patient and provider barriers to the use of diabetes technology.
Contemporary Diabetes Management With Smart Technology: Case Studies in Continuous Glucose Monitoring (IME Content)
Various case studies to explore the use of Continuous Glucose Monitoring.
Smart Technology for Diabetes Management: Advances for Insulin Delivery Methods (IME Content)
Comprehensive overview of various insulin delivery devices.
Glucagon-Like Peptide-1 Receptor Agonists (GLP-1 RAs) and Type 1 Diabetes
Summary of prescribing information and clinical trial experience regarding Novo Nordisk GLP-1 RAs and type 1 diabetes.
Continuing Education
Find accredited opportunities in type 1 diabetes education.
Type 1 Diabetes
Type 1 Diabetes
Looking for additional resources?
Explore other libraries or search the Exchange.
Additional Information
Speak to a live medical representative.
If you are a healthcare provider from the United States, click below to request information directly from the Novo Nordisk Medical Information department. If you are a patient, please visit here to contact us, or call 1-800-727-6500.
Search the Medical Information Database
The Scientific Exchange is a resource for U.S. Healthcare Professionals to learn more about disease states investigated by Novo Nordisk and our related products.
Scientific Exchange is a trademark of Novo Nordisk Health Care AG.
Novo Nordisk is a registered trademark of Novo Nordisk A/S.
Non-US Health Care Professionals, please go to www.novonordiskpro.com.
